Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Young-Eun Joo*, Hyun-Kyung Park†, Dae-Seong Myung*, Gwang-Ho Baik‡, Jeong-Eun Shin§, Geom-Seog Seo∥, Gwang Ha Kim¶, Heung Up Kim#, Hyun Young Kim†, Sung-Il Cho**, and Nayoung Kim†*
*Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
†Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
‡Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
§Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
∥Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.
¶Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
#Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
**School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, Korea.
Correspondence to: Nayoung Kim. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707, Korea. Tel: +82-31-787-7008, Fax: +82-31-787-4051, nayoungkim49@empas.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2013;7(3):303-310. https://doi.org/10.5009/gnl.2013.7.3.303
Published online May 13, 2013, Published date May 31, 2013
Copyright © Gut and Liver.
Atrophic gastritis (AG) and intestinal metaplasia (IM) are premalignant gastric lesions. The aims of this study were to evaluate the prevalence of endoscopic AG and IM and to document the risk factors for these lesions.
In total, 4,023 subjects were enrolled at eight hospitals in Korea. AG and IM were diagnosed by endoscopy.
The prevalences of endoscopic AG and IM were 40.7% and 12.5%. In a multivariate analysis, the risk factors for AG were age groups of 40 to 59 years and >60 years, male sex, positive
A nationwide survey regarding the prevalence of endoscopic AG and IM and their risk factors in Korea supports the hypothesis that endoscopic diagnosis of these premalignant lesions could be helpful to describe a group at high risk for gastric cancer.
Keywords: Atrophic gastritis, Intestinal metaplasia, Prevalence, Risk factors, Endoscopy
Gastric cancer, the incidence of which became declining in many industrialized countries, is still one of the major causes of mortality from cancer death in the world.1 Whereas the postoperative 5-year survival rates are 90% to 95% for early gastric cancer (EGC), only 20% to 40% of patients with advanced gastric cancer are expected to survive for 5 years or more.2-4 Moreover, surgery is no more needed in a considerable fraction of patients who are diagnosed with EGC, owing to recent advances in endoscopic resection techniques and technologies. Therefore, early detection of EGC through the vigilant follow-up in the high risk groups is probably the effective strategy for improving survival and quality of life.
The pathogenesis of gastric cancer, particularly the intestinal type, can be explained by a cascade from chronic gastritis through atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia to cancer. AG is characterized by chronic inflammatory processes of gastric mucosa that leads to the loss of glandular structure and a reduction of gastric secretory function. The presence of AG is known to be a risk of gastric cancer, which increases with the degree and extension of atrophy.5 IM is defined as replacement of gastric columnar epithelial cells by cells of intestinal morphology with the presence of goblet cells, Paneth cells and absorptive cells.5 Both AG and IM represent an obligatory transitional step in gastric carcinogenesis and are undisputed indicators of an increased risk for gastric cancer as compared with chronic gastritis in the absence of these lesions.5-7 Therefore, the recognition of these lesions by endoscopy in a general population indicates the necessity of follow-up endoscopy, which helps the early detection of gastric cancer leading to a better prognosis and treatment by endoscopic resection.
The prevalence of AG and IM vary among countries. That is, they are relatively high in countries with a higher prevalence of
In Western countries, AG and IM are generally observed in histological examination of random biopsies obtained during endoscopy, whereas in Asian countries including Korea, the presence and extension of AG and IM are frequently observed by endoscopy. A health check-up program designed to detect gastric cancer was implemented by the South Korean government in 2001 for biannual evaluation of Korean citizens over age 40. Thus, if we know the endoscopic prevalence of AG and IM in the general population and their role in the localization of high risk group of gastric cancer, it would be very useful for prevention of gastric cancer.
From this background, the aims of this study were to evaluate the prevalence of endoscopic AG and IM, and to document the risk factors for the development of these precancerous lesions with the special reference to
A total of 4,023 subjects who underwent screening endoscopy during a routine general check-up from January to December in 2011, were prospectively enrolled at eight nationwide healthcare centers in Korea. Subjects with a history of gastrointestinal surgery or with systemic disease requiring chronic medication except hypertension and diabetes mellitus were excluded. This study was reviewed and approved by the Institutional Review Board of the eight participating hospitals and written informed consent was obtained from all participating subjects.
All subjects, who provided informed consents, underwent a clinical interview based on a structured questionnaire to assess personal and clinical data under the supervision of a well-trained interviewer before the endoscopy at the eight participating healthcare centers. The questionnaire included questions regarding demographic data, the presence of upper gastrointestinal symptoms, such as epigastric pain or discomfort, dyspepsia, epigastric soreness, and abdominal pain during the previous year, comorbid disease, history of
All of the endoscopic examinations were carried out and assessed by endoscopy experts of the eight participating healthcare centers. The endoscopic findings were examined, in a standardized manner, for typical macroscopic changes including erythema (diffuse, spotty, or linear), erosions (small superficial defects in the mucosa with flat edge and white/yellow color or small bleeding spots [petechiae]), absence of rugae, and visible blood vessels. Investigators did agree with simplification of endoscopic definition about AG and IM. Endoscopic AG was defined as thinning, whitish mucosal change or visible submucosal vascular patterns and endoscopic IM as white plaque-like elevation in antrum and corpus. Any overlapping findings were described.
Blood samples were obtained from each participant immediately after endoscopy. Isolated serum samples were neatly arranged in storage boxes and stored at -70℃.
All statistical analyses were performed using the Stat View software package (SAS Institute, Cary, NC, USA). Continuous variables were analyzed by Student's t-test. Categorical variables were analyzed using chi-squared test or Fisher's exact test. Multivariate logistic regression was used for the analysis of risk factors, which were expressed as the odds ratio (OR) and 95% confidence intervals (CI). The p-values of less than 0.05 were considered statistically significant.
A total of 4,023 subjects were included in the study. This study group comprised 2,358 males (58.6%) and 1,665 females (41.4%). The mean age was 48.7±11.3 (mean±standard deviation [SD]) years with a range from 15 to 98 years.
The prevalence rates of AG and IM, diagnosed by endoscopic findings, were 40.7% (1,638 of 4,023) and 12.5% (502 of 4,023), respectively. The prevalence rates of AG and IM in males were significantly higher than those in females (43.3% vs 37.1% and 15.4% vs 8.3%, respectively; p<0.001) (Tables 2 and 3). The prevalence rate of AG increased with age (from 29.9% in those aged less than 40 years to 59.4% in those aged 60 years or older) (Fig. 1A). The prevalence rate of IM also increased with age (from 3.4% in those less than 40 years of age to 17.4% in those 60 years or older; p<0.001) (Fig. 1B).
In a univariate analysis of risk factors for AG, older age group of above 40 to 59, older age group of above 60 years, male gender,
In a univariate analysis of risk factors for IM, older age group of above 40 to 59, older age group of above 60 years, male gender,
The development of gastric cancer is generally accepted to be a multistep progression from
However, it is nearly impossible to take biopsy from antrum and body in the general population without definite lesion, especially in a huge population as our study. Thus, it is necessary to evaluate prevalence rates of endoscopic AG and IM, especially where the health check-up endoscopy is popular for gastric cancer screening. In the present study, the prevalence of AG and IM were found to be 40.7% and 12.5%, respectively. In Western Europe, the overall prevalence rates of AG and IM were approximately one-third and one-fourth of subjects, respectively.12-14 In contrast, the prevalence of AG and IM were 55.5% and 28.5%, respectively, in Japan.15 Previously, we have shown that the prevalence rates of AG and IM, diagnosed by histology, were 42.5% and 28.6%, respectively in the antrum.8 Considering histological diagnosis of IM is more accurate and sensitive than endoscopic diagnosis,13,16 the prevalence rate of endoscopic IM in the present study, 12.5%, is not very low. Another reason of lower prevalence of IM in this study could be explained by the population of the participating subjects: 21.5% was below 40 years old, and only 16.7% was ≥60.
In our study, the prevalence of AG and IM increased significantly with age and this phenomenon could be explained by
Interestingly, AG and IM were found to be a risk factor for each other in our study. Usually, these two lesions have been associated with chronic inflammatory processes such as
In our study, low education below college was a risk factor for the development of AG and IM. Previous reports showed that lower education was associated with
The proportion of family history of gastric cancer was found to be 11% in this study, rather higher than that in the general population. This could be originated from more concern of the relatives of gastric cancer about their health they might frequently receive health check-up, compared general population. Interestingly, family history of gastric cancer was a risk factor for the development of IM, but not of AG in our study. First-degree relatives of gastric cancer were found to have a higher risk of developing gastric cancer.24,25 The possible causes of familial aggregation of gastric cancer are not only genetic factors but also environmental factors including
Similar to the family history of gastric cancer, consumption of dairy product at least five times per week was a risk factor for the development of IM but not AG. Previously, milk or yogurt prevents the development of AG and IM through its defense mechanism against the attachment of
Our study has limitations. The diagnosis of AG and IM was made only by endoscopic findings and not confirmed by histology. Although histological examination is considered as the gold standard for diagnoses of AG and IM, interobserver variation for diagnoses of AG on biopsy specimens has been shown to be high,33,34 and sampling errors exist, especially when multifocal AG is present.35,36 Also, there are few reports concerning the high agreement between the endoscopic and histological atrophy scores.37,38 The image quality of conventional endoscopes has improved dramatically over the last decade and typical endoscopic findings are interpreted as signs of AG and IM. In addition, to prevent the interobserver variation in the diagnosis of AG and IM, only endoscopic experts participated in this study. Even though the significance of typical endoscopic findings in relation to histology is still uncertain,16,39 similar results regarding the prevalence and risk factor of endoscopic AG and IM to those from the histological AG and IM support clinical significance of our study. Also, the severity and location of endoscopic AG and IM were not classified mainly because there is no standardized grading system of atrophy and IM. In addition, as the endoscopy of this study was performed as one of health check-up it was very difficult to ask the participating doctors to fill up all of those things in detail.
In conclusion, the prevalence of endoscopic AG and IM in the general population were not so high in Korea, especially in case of IM. The risk factors of AG and IM were similar but relatives of gastric cancer and consumption of dairy product were the risk factors of IM, but not of AG. Therefore, it is worthwhile to describe the degree and extent of AG and IM in detail during endoscopy, according to diagnostic criteria.
Data are presented as mean±SD or number (%).
NSAID, nonsteroidal anti-inflammatory drug;
NSAID, nonsteroidal anti-inflammatory drug;
Data are presented as number (%).
*Some data were missing. Missing values were not included.
NSAID, nonsteroidal anti-inflammatory drug;
Data are presented as number (%).
IM, intestinal metaplasia;
*Some data were missing. Missing values were not included.
NSAID, nonsteroidal anti-inflammatory drug;
B, estimate; SE, standard error; Exp(β), odds ratio; CI, confidence interval;
NSAID, nonsteroidal anti-inflammatory drug;
B, estimate; SE, standard error; Exp(β), odds ratio; CI, confidence interval;
NSAID, nonsteroidal anti-inflammatory drug;
Gut Liver 2013; 7(3): 303-310
Published online May 31, 2013 https://doi.org/10.5009/gnl.2013.7.3.303
Copyright © Gut and Liver.
Young-Eun Joo*, Hyun-Kyung Park†, Dae-Seong Myung*, Gwang-Ho Baik‡, Jeong-Eun Shin§, Geom-Seog Seo∥, Gwang Ha Kim¶, Heung Up Kim#, Hyun Young Kim†, Sung-Il Cho**, and Nayoung Kim†*
*Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
†Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
‡Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
§Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
∥Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.
¶Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
#Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
**School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, Korea.
Correspondence to: Nayoung Kim. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707, Korea. Tel: +82-31-787-7008, Fax: +82-31-787-4051, nayoungkim49@empas.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Atrophic gastritis (AG) and intestinal metaplasia (IM) are premalignant gastric lesions. The aims of this study were to evaluate the prevalence of endoscopic AG and IM and to document the risk factors for these lesions.
In total, 4,023 subjects were enrolled at eight hospitals in Korea. AG and IM were diagnosed by endoscopy.
The prevalences of endoscopic AG and IM were 40.7% and 12.5%. In a multivariate analysis, the risk factors for AG were age groups of 40 to 59 years and >60 years, male sex, positive
A nationwide survey regarding the prevalence of endoscopic AG and IM and their risk factors in Korea supports the hypothesis that endoscopic diagnosis of these premalignant lesions could be helpful to describe a group at high risk for gastric cancer.
Keywords: Atrophic gastritis, Intestinal metaplasia, Prevalence, Risk factors, Endoscopy
Gastric cancer, the incidence of which became declining in many industrialized countries, is still one of the major causes of mortality from cancer death in the world.1 Whereas the postoperative 5-year survival rates are 90% to 95% for early gastric cancer (EGC), only 20% to 40% of patients with advanced gastric cancer are expected to survive for 5 years or more.2-4 Moreover, surgery is no more needed in a considerable fraction of patients who are diagnosed with EGC, owing to recent advances in endoscopic resection techniques and technologies. Therefore, early detection of EGC through the vigilant follow-up in the high risk groups is probably the effective strategy for improving survival and quality of life.
The pathogenesis of gastric cancer, particularly the intestinal type, can be explained by a cascade from chronic gastritis through atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia to cancer. AG is characterized by chronic inflammatory processes of gastric mucosa that leads to the loss of glandular structure and a reduction of gastric secretory function. The presence of AG is known to be a risk of gastric cancer, which increases with the degree and extension of atrophy.5 IM is defined as replacement of gastric columnar epithelial cells by cells of intestinal morphology with the presence of goblet cells, Paneth cells and absorptive cells.5 Both AG and IM represent an obligatory transitional step in gastric carcinogenesis and are undisputed indicators of an increased risk for gastric cancer as compared with chronic gastritis in the absence of these lesions.5-7 Therefore, the recognition of these lesions by endoscopy in a general population indicates the necessity of follow-up endoscopy, which helps the early detection of gastric cancer leading to a better prognosis and treatment by endoscopic resection.
The prevalence of AG and IM vary among countries. That is, they are relatively high in countries with a higher prevalence of
In Western countries, AG and IM are generally observed in histological examination of random biopsies obtained during endoscopy, whereas in Asian countries including Korea, the presence and extension of AG and IM are frequently observed by endoscopy. A health check-up program designed to detect gastric cancer was implemented by the South Korean government in 2001 for biannual evaluation of Korean citizens over age 40. Thus, if we know the endoscopic prevalence of AG and IM in the general population and their role in the localization of high risk group of gastric cancer, it would be very useful for prevention of gastric cancer.
From this background, the aims of this study were to evaluate the prevalence of endoscopic AG and IM, and to document the risk factors for the development of these precancerous lesions with the special reference to
A total of 4,023 subjects who underwent screening endoscopy during a routine general check-up from January to December in 2011, were prospectively enrolled at eight nationwide healthcare centers in Korea. Subjects with a history of gastrointestinal surgery or with systemic disease requiring chronic medication except hypertension and diabetes mellitus were excluded. This study was reviewed and approved by the Institutional Review Board of the eight participating hospitals and written informed consent was obtained from all participating subjects.
All subjects, who provided informed consents, underwent a clinical interview based on a structured questionnaire to assess personal and clinical data under the supervision of a well-trained interviewer before the endoscopy at the eight participating healthcare centers. The questionnaire included questions regarding demographic data, the presence of upper gastrointestinal symptoms, such as epigastric pain or discomfort, dyspepsia, epigastric soreness, and abdominal pain during the previous year, comorbid disease, history of
All of the endoscopic examinations were carried out and assessed by endoscopy experts of the eight participating healthcare centers. The endoscopic findings were examined, in a standardized manner, for typical macroscopic changes including erythema (diffuse, spotty, or linear), erosions (small superficial defects in the mucosa with flat edge and white/yellow color or small bleeding spots [petechiae]), absence of rugae, and visible blood vessels. Investigators did agree with simplification of endoscopic definition about AG and IM. Endoscopic AG was defined as thinning, whitish mucosal change or visible submucosal vascular patterns and endoscopic IM as white plaque-like elevation in antrum and corpus. Any overlapping findings were described.
Blood samples were obtained from each participant immediately after endoscopy. Isolated serum samples were neatly arranged in storage boxes and stored at -70℃.
All statistical analyses were performed using the Stat View software package (SAS Institute, Cary, NC, USA). Continuous variables were analyzed by Student's t-test. Categorical variables were analyzed using chi-squared test or Fisher's exact test. Multivariate logistic regression was used for the analysis of risk factors, which were expressed as the odds ratio (OR) and 95% confidence intervals (CI). The p-values of less than 0.05 were considered statistically significant.
A total of 4,023 subjects were included in the study. This study group comprised 2,358 males (58.6%) and 1,665 females (41.4%). The mean age was 48.7±11.3 (mean±standard deviation [SD]) years with a range from 15 to 98 years.
The prevalence rates of AG and IM, diagnosed by endoscopic findings, were 40.7% (1,638 of 4,023) and 12.5% (502 of 4,023), respectively. The prevalence rates of AG and IM in males were significantly higher than those in females (43.3% vs 37.1% and 15.4% vs 8.3%, respectively; p<0.001) (Tables 2 and 3). The prevalence rate of AG increased with age (from 29.9% in those aged less than 40 years to 59.4% in those aged 60 years or older) (Fig. 1A). The prevalence rate of IM also increased with age (from 3.4% in those less than 40 years of age to 17.4% in those 60 years or older; p<0.001) (Fig. 1B).
In a univariate analysis of risk factors for AG, older age group of above 40 to 59, older age group of above 60 years, male gender,
In a univariate analysis of risk factors for IM, older age group of above 40 to 59, older age group of above 60 years, male gender,
The development of gastric cancer is generally accepted to be a multistep progression from
However, it is nearly impossible to take biopsy from antrum and body in the general population without definite lesion, especially in a huge population as our study. Thus, it is necessary to evaluate prevalence rates of endoscopic AG and IM, especially where the health check-up endoscopy is popular for gastric cancer screening. In the present study, the prevalence of AG and IM were found to be 40.7% and 12.5%, respectively. In Western Europe, the overall prevalence rates of AG and IM were approximately one-third and one-fourth of subjects, respectively.12-14 In contrast, the prevalence of AG and IM were 55.5% and 28.5%, respectively, in Japan.15 Previously, we have shown that the prevalence rates of AG and IM, diagnosed by histology, were 42.5% and 28.6%, respectively in the antrum.8 Considering histological diagnosis of IM is more accurate and sensitive than endoscopic diagnosis,13,16 the prevalence rate of endoscopic IM in the present study, 12.5%, is not very low. Another reason of lower prevalence of IM in this study could be explained by the population of the participating subjects: 21.5% was below 40 years old, and only 16.7% was ≥60.
In our study, the prevalence of AG and IM increased significantly with age and this phenomenon could be explained by
Interestingly, AG and IM were found to be a risk factor for each other in our study. Usually, these two lesions have been associated with chronic inflammatory processes such as
In our study, low education below college was a risk factor for the development of AG and IM. Previous reports showed that lower education was associated with
The proportion of family history of gastric cancer was found to be 11% in this study, rather higher than that in the general population. This could be originated from more concern of the relatives of gastric cancer about their health they might frequently receive health check-up, compared general population. Interestingly, family history of gastric cancer was a risk factor for the development of IM, but not of AG in our study. First-degree relatives of gastric cancer were found to have a higher risk of developing gastric cancer.24,25 The possible causes of familial aggregation of gastric cancer are not only genetic factors but also environmental factors including
Similar to the family history of gastric cancer, consumption of dairy product at least five times per week was a risk factor for the development of IM but not AG. Previously, milk or yogurt prevents the development of AG and IM through its defense mechanism against the attachment of
Our study has limitations. The diagnosis of AG and IM was made only by endoscopic findings and not confirmed by histology. Although histological examination is considered as the gold standard for diagnoses of AG and IM, interobserver variation for diagnoses of AG on biopsy specimens has been shown to be high,33,34 and sampling errors exist, especially when multifocal AG is present.35,36 Also, there are few reports concerning the high agreement between the endoscopic and histological atrophy scores.37,38 The image quality of conventional endoscopes has improved dramatically over the last decade and typical endoscopic findings are interpreted as signs of AG and IM. In addition, to prevent the interobserver variation in the diagnosis of AG and IM, only endoscopic experts participated in this study. Even though the significance of typical endoscopic findings in relation to histology is still uncertain,16,39 similar results regarding the prevalence and risk factor of endoscopic AG and IM to those from the histological AG and IM support clinical significance of our study. Also, the severity and location of endoscopic AG and IM were not classified mainly because there is no standardized grading system of atrophy and IM. In addition, as the endoscopy of this study was performed as one of health check-up it was very difficult to ask the participating doctors to fill up all of those things in detail.
In conclusion, the prevalence of endoscopic AG and IM in the general population were not so high in Korea, especially in case of IM. The risk factors of AG and IM were similar but relatives of gastric cancer and consumption of dairy product were the risk factors of IM, but not of AG. Therefore, it is worthwhile to describe the degree and extent of AG and IM in detail during endoscopy, according to diagnostic criteria.
Table 1 Baseline Characteristics of the 4,023 Subjects
Data are presented as mean±SD or number (%).
NSAID, nonsteroidal anti-inflammatory drug;
NSAID, nonsteroidal anti-inflammatory drug;
Table 2 Univariate Analysis of the Risk Factors for Atrophic Gastritis
Data are presented as number (%).
*Some data were missing. Missing values were not included.
NSAID, nonsteroidal anti-inflammatory drug;
Table 3 Univariate Analysis of the Risk Factors for Intestinal Metaplasia
Data are presented as number (%).
IM, intestinal metaplasia;
*Some data were missing. Missing values were not included.
NSAID, nonsteroidal anti-inflammatory drug;
Table 4 Multivariate Analysis of the Risk Factors for Atrophic Gastritis
B, estimate; SE, standard error; Exp(β), odds ratio; CI, confidence interval;
NSAID, nonsteroidal anti-inflammatory drug;
Table 5 Multivariate Analysis of the Risk Factors for Intestinal Metaplasia
B, estimate; SE, standard error; Exp(β), odds ratio; CI, confidence interval;
NSAID, nonsteroidal anti-inflammatory drug;